IMM CHART / SP, page-51

To those who panicked since Daq's irrelevance and acted on that panicking yesterday and to those who opportunisticaly wanted to push IMM off the cliff;

How is your serenity?!

And yes, Daq is irrelevant. Data/results talk.

in that regard, @lotu54, in biotech data talks. No chart-eologist can possibly predict progression free survival (or other clinical indicators) in trials. We have seen not even MV can, and if one pretends, it can be disastrous. And data is only revealed when results are announced and that, by definition, is too late for a char to tell us what the future is.

So, my opinion is for myself, ditch chart for those kinda purposes and educate yourself to underestand the science, the product, the company and the sector more, to help make the right decision, as otherwise, it is gambling using a chart-machine, maybe instead of poker-machine